Risk of breast cancer among women is not equal in both breasts after a diagnosis of atypical lobular hyperplasia, say clinicians in the United States.
Their findings challenge the current belief that risk is equal in both breasts after a diagnosis of atypical lobular hyperplasia, declare Dr David Page and colleagues at the Vanderbilt Medical Center, Nashville, Tennessee.
This emerges in a retrospect study among women who took part in the Nashville Breast Studies. There is increasing recognition that risk implications for the various components of lobular neoplasia–atypical lobular hyperplasia versus ductal involvement with cells of atypical lobular hyperplasia versus lobular carcinoma in situ– vary with the amount of histological evidence, the researchers point out. Risk of breast cancer after atypical lobular hyperplasia can also vary with respect to menopausal status.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!